Neurogene, Inc. Common Stock Made Headway
Mon, Nov 04, 2024 at 07:34 PM
Neurogene, Inc. Common Stock (NGNE:NASDAQ) jumped higher at $66, representing a gain of 43.3%. On Mon, Nov 04, 2024, NGNE:NASDAQ hit a New 2-Week High of $66. The stock appeared on our News Catalysts scanner on Mon, Nov 04, 2024 at 10:07 AM in the 'PRIVATE PLACEMENT' category. From Tue, Oct 22, 2024, the stock recorded 44.44% Up Days and 30.00% Green Days
About Neurogene, Inc. Common Stock (NGNE:NASDAQ)
Neoleukin Therapeutics Inc operates as a biopharmaceutical company. The firm generates immunotherapies using de novo protein design technology.
Top 10 Gainers:
- SIMPPLE LTD. (SPPL:NASDAQ), 268.75%
- Nuwellis Inc. (NUWE:NASDAQ), 106.62%
- Advent Technologies Holdings Inc. (ADN:NASDAQ), 76.32%
- Singular Genomics Systems Inc. (OMIC:NASDAQ), 65.75%
- Staffing 360 Solutions, Inc. (STAF:NASDAQ), 65.12%
- Earlyworks Co. Ltd. (ELWS:NASDAQ), 55.52%
- Neurogene, Inc. Common Stock (NGNE:NASDAQ), 43.26%
- Vast Renewables Limited (VSTE:NASDAQ), 40.63%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 39.07%
- Hanryu Holdings, Inc. (HRYU:NASDAQ), 33.94%